Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age-related patterns for high-risk and low-risk types

International Journal of Cancer

Volumn 87, Issue 2, 2000, Pages 221-227

  Jacobs, Marcel V ^a   Walboomers, Jan M M ^a   Snijders, Peter J F ^a   Voorhorst, Feja J ^a   Verheijen, Rene H M ^a   Fransen Daalmeijer, Nathalie ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PREVALENCE; REFERENCE VALUES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034662088     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2     Document Type: Article

References (22)

1. BOSCH, F.X., MANOS, M.M., MUÑOZ, N., SHERMAN, M., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KURMAN, R., SHAH, K.V., and IBSCC STUDY GROUP. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Nat. Cancer Inst., 87, 796-802 (1995).
2. BURK, D.B., KELLY, P., FELDMAN, J., BROMBERG, J., VERMUND, S.H., DEHOVITZ, J.A., and LANDESMAN, S.H. Declining prevalence of cervico-vaginal human papillomavirus infection with age is independent of other risk factors. Sex. Trans. Dis., 23, 333-341 (1996).
3. DE RODA HUSMAN, A.M., WALBOOMERS, J.M.M., MEIJER, C.J.L.M., RISSE, E.J.K., SCHIPPER, M.E.I., HELMERHORST, TH.J.M., BLEKER, O.P., DELIUS, H., VAN DEN BRULE, A.J.C., and SNIJDERS, P.J.F. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int. J. Cancer, 56, 82-86 (1994).
4. DE RODA HUSMAN, A.M., WALBOOMERS, J.M.M., VAN DEN BRULE, A.J.C., MEIJER, C.J.L.M., and SNIJDERS, P.J.F. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by polymerase chain reaction. J. Gen. Virol., 76, 412-417 (1995).
5. HILDESHEIM, A., SCHIFFMAN, M.H., GRAVTIT, P.E., GLASS, A.G., GREER, C.E., ZHANG, T., SCOTT, D.R., RUSH, B.B., LAWLER, P., SHERMAN, M.E., KURMAN, R.J., and MANOS, M.M. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis., 169, 235-240 (1994).
6. IARC. Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol 64. Lyon: International Agency for Research on Cancer, (1995).
7. JACOBS, M.V., SNIJDERS, P.J.F., VAN DEN BRULE, A.J.C., HELMERHORST, TH.J., MEIJER, C.J.L.M. and WALBOOMERS, J.M.M. A general primer GP5+/6+ mediated polymerase chain reaction-enxyme immunoassay method for rapid detection of 14 high risk and 6 low risk human papillomavirus genotypes in cervical scrapes. J. Clin. Microbiol., 35, 791-795 (1997).
8. JACOBS, M.V., WALBOOMERS, J.M.M., SNIJDERS, P.J.F., and MEIJER, C.J.L.M. General primer GP5+/6+ mediated polymerase chain reaction-enzyme immunoassay for the detection of human papillomaviruses in cervical scrapes. In: J. Cason and N. Punchard (eds.), Methods in molecular medicine, in press.
9. JACOBS, M.V., WALBOOMERS, J.M.M., VAN BEEK, J., VERHEIJEN, R.H.M., MEIJER, C.J.L.M., VAN DEN BRULE, A.J.C., HELMERHORST, TH.J.M., and SNEIDERS, P.J.F. A quantitative polymerase chain reaction-enzyme immunoassay method for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings. Brit. J. Cancer, 81, 114-122, 1999.
10. KJÆR, S.K., VAN DEN BRULE, A.J.C., BOCK, J.E., POLL, P.A., ENGHOLM, G., SHERMAN, M.E., WALBOOMERS, J.M.M., and MEIJER, C.J.L.M. Human papillomavirus: the most significant risk determinant of cervical intraepithelial neoplasia. Int. J. Cancer, 65, 601-606 (1996).
11. LIAW, K-I., GLASS, A.G., MANOS, M.M., GREER, C.E., SCOTT, D.R., SHERMAN, M., BURK, R.D., KURMAN, R.J., WACHOLDER, S., RUSH, B.B., CADELL, D.M., LAWLER, P., TABOR, D., and SCHIFFMAN, M. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J. nat. Cancer Inst., 91, 954-960 (1999).
12. LÖRINCZ, A.T., REID, R., JENSON, A.B., GREENBERG, M.D., LANCASTER, W., and KURMAN, R.J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol., 79, 328-337 (1992).
13. MCNEIL, C. HPV vaccines for cervical cancer move towards clinic, encounter social issues. J. Nat. Cancer Inst., 89, 1664-1666 (1997).
14. MELKERT, P.W.J., HOPMAN, E., VAN DEN BRULE, A.J.C., RISSE, E.J.K., VAN DIEST, P.J., BLEKER, O.P., HELMERHORST, TH.J., SCHIPPER, M.E.I., MEIJER, C.J.L.M., and WALBOOMERS, J.M.M. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymcrase chain reaction, is age-dependent. Int. J. Cancer, 53, 1-5 (1993).
15. MEIJER, C.J.L.M., VAN DEN BRULE, A.J.C., SNIJDERS, P.J.F., HELMERHORST, TH.J.M., KENEMANS, P., and WALBOOMERS, J.M.M. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. In: The epidemiology of cervical cancer and human papillomavirus, pp. 271-281, International Agency for Research on Cancer, Lyon (1992).
16. MYERS, G., BERNARD, H.U., FAVRE, M., ICENOGUE, J., VAN RANST, M., and WHEELER, C. A compilation and analysis of nucleic acid and amino acid sequences. Human Papillomavirus Compendium, 1994-1997.
17. ROZENDAAL, L., WALBOOMERS, J.M.M., VAN DER LINDEN, J.C., VOORHORST, F.J., KENEMANS, P., HELMERHORST, TH.J. M., VAN BALLEGOOYEN, M., and MEIJER, C.J.L.M. PCR-based high risk HPV test in cervical-cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int. J. Cancer, 68, 766-769 (1996).
18. VOOUS, G.P. De advisering bij afwijkende bevindingen van cytologisch onderzoek van de cervix uteri. Ned. Tijdschr. Geneesk., 131, 1662-1663 (1987).
19. VAN DEN BRULE, A.J.C., SNIJDERS, P.J.K. GORDIJN, R.L.J., BLEKER, O.P., MEIJER, C.J.L.M., and WALBOOMERS, J.M.M. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int. J. Cancer. 45, 644-649 (1990).
20. WALBOOMERS, J.M.M., JACOBS, M.V., MANOS, M.M., BOSCH, F.X., KUMMER, A.J., SHAH, K.V., SNIJDERS, P.J.F., PETO, J., MEIJER, C.J.L.M., and MUÑOZ, N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189, 12-19 (1999).
21. WALBOOMERS, J.M.M., MELKERT, P.W.J., VAN DEN BRULE, A.J.C., SNIJDERS, P.J.F., and MEIJER, C.J.L.M. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. In: C.S. Herrington and O'D. McGee (eds.), Diagnostic molecular pathology: a practical approach, Vol. II, pp. 152-172, Oxford University Press, Oxford (1992).
22. ZUR HAUSEN, H. Molecular pathogenesis of cancer of the cervix uteri and its causation by specific human papilloma virus types. In: H. Zur Hausen (ed.), Human pathogenic papillomaviruses, pp. 131-156, SpringerVerlag, Berlin (1994).